What You Should Know: – mpathic, the leader in AI-powered actionable conversation analytics specializing in healthcare, life sciences, and client services was recently awarded an
Dive Brief: Element Biosciences said Wednesday it raised $277 million in a Series D financing round, giving the company additional capital to challenge Illumina in
Dive Brief: J&J has limited the use of three models of Megadyne patient return electrodes due to the risk of burns. In a June recall
Dive Brief: The Food and Drug Administration has finalized guidance on clinical considerations for studies of devices intended to treat opioid use disorder. Through the
Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks
The cerebellum, often referred to as the ‘little brain’, has captivated researchers for centuries due to its unique structure and cellular complexity, as one of
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s
People tend to become less narcissistic as they age from childhood through older adulthood, according to a study published by the American Psychological Association.
In this Issue Lykos Insiders, Affiliates, Respond to Critics Might FDA Miss Its August 11th Goal Date? FDA-Affiliated Workshop Discusses Ketamine’s Use In Mental Health
Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of